About Us

Travera was founded in 2017 to commercialize a breakthrough measurement technology and biomarker developed in the Manalis Laboratory in the Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology (MIT).

The company’s initial test is based on this technology; a new measurement tool called the Suspended Microchannel Resonator (SMR) that makes exquisitely precise measurements of the effects of cancer drugs on cancer cells.

Leadership Team

 

Travera’s leadership team is comprised of experienced business executives and researchers who are responsible for defining and implementing the company’s strategy to offer a test which provides physicians and their patients a personalized approach to cancer treatment .

Development Team

Advisors

99A Erie Street Cambridge, MA 02139